287 related articles for article (PubMed ID: 32841918)
41. Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.
Campos MS; Ayres LR; Morelo MR; Marques FA; Pereira LR
Pharmacotherapy; 2016 Dec; 36(12):1255-1271. PubMed ID: 27779771
[TBL] [Abstract][Full Text] [Related]
42. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
[TBL] [Abstract][Full Text] [Related]
43. Is autonomic nervous system involved in restless legs syndrome during wakefulness?
Izzi F; Placidi F; Romigi A; Lauretti B; Marfia GA; Mercuri NB; Marciani MG; Rocchi C
Sleep Med; 2014 Nov; 15(11):1392-7. PubMed ID: 25266501
[TBL] [Abstract][Full Text] [Related]
44. Cardiovascular autonomic functions in well-controlled and intractable partial epilepsies.
Mukherjee S; Tripathi M; Chandra PS; Yadav R; Choudhary N; Sagar R; Bhore R; Pandey RM; Deepak KK
Epilepsy Res; 2009 Aug; 85(2-3):261-9. PubMed ID: 19409754
[TBL] [Abstract][Full Text] [Related]
45. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ
Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
[TBL] [Abstract][Full Text] [Related]
46. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
[TBL] [Abstract][Full Text] [Related]
47. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.
Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM
Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854
[TBL] [Abstract][Full Text] [Related]
48. Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center.
Baker MD; Abou-Khalil BW; Arain A; Tummala P; Azar NJ; Haas KF; Sonmezturk HH
Clin Neurol Neurosurg; 2018 Aug; 171():179-183. PubMed ID: 29929174
[TBL] [Abstract][Full Text] [Related]
49. Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patients.
Böttcher S; Lutz MT; Mayer T
Epilepsia; 2017 Oct; 58(10):1749-1754. PubMed ID: 28804872
[TBL] [Abstract][Full Text] [Related]
50. Outcomes following exposure to lacosamide monotherapy during pregnancy and breastfeeding - a prospective case series.
Bosak M; Dziedzic R; Matwiej K; Słowik A
Neurol Neurochir Pol; 2024; 58(2):203-206. PubMed ID: 38305480
[TBL] [Abstract][Full Text] [Related]
51. Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in mice.
Shandra A; Shandra P; Kaschenko O; Matagne A; Stöhr T
Epilepsia; 2013 Jul; 54(7):1167-75. PubMed ID: 23750855
[TBL] [Abstract][Full Text] [Related]
52. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
[TBL] [Abstract][Full Text] [Related]
53. Status epilepticus developing during lacosamide monotherapy.
Papacostas SS
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25628098
[TBL] [Abstract][Full Text] [Related]
54. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
Groth A; Wilke T; Borghs S; Gille P; Joeres L
Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
[No Abstract] [Full Text] [Related]
55. Lacosamide in patients with epilepsy of cerebrovascular etiology.
Rosenow F; Brandt C; Bozorg A; Dimova S; Steiniger-Brach B; Zhang Y; Ferrò B; Holmes GL; Kälviäinen R
Acta Neurol Scand; 2020 Jun; 141(6):473-482. PubMed ID: 32068241
[TBL] [Abstract][Full Text] [Related]
56. A clinical efficacy experience of Lacosamide on sleep quality in patients with Nocturnal Frontal Lobe Epilepsy (NFLE).
Mangiardi M; Alfano G
Acta Biomed; 2018 Oct; 89(3):397-399. PubMed ID: 30333465
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.
Pazdera L; Sperling MR; Harvey JH; Sam MC; Strom LA; Blum D; Grinnell T; Cheng H
Epilepsia; 2018 Mar; 59(3):704-714. PubMed ID: 29450890
[TBL] [Abstract][Full Text] [Related]
58. Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy.
Eun SH; Eun BL; Lee JS; Hwang YS; Kim KJ; Lee YM; Lee IG; Lee M; Ko TS; Kim JT; Eom S; Kim HD
Brain Dev; 2012 Nov; 34(10):818-23. PubMed ID: 22521904
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
[TBL] [Abstract][Full Text] [Related]
60. [Lacosamide in treatment of patients with focal epilepsy and comorbid mental disorders].
Yakovleva YA; Yanaeva AN; Spikina AA; Rukavitsyna EL
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10. Vyp. 2):98-104. PubMed ID: 30698552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
